According to Mersana Therapeutics's latest financial reports the company's total assets are $0.22 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.22 B | -32.39% |
2022-12-31 | $0.33 B | 62.21% |
2021-12-31 | $0.20 B | -24.61% |
2020-12-31 | $0.27 B | 154.23% |
2019-12-31 | $0.10 B | 36.99% |
2018-12-31 | $78.5 M | -39.94% |
2017-12-31 | $0.13 B | 24.39% |
2016-12-31 | $0.10 B | 629.32% |
2015-12-31 | $14.4 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 11.48% | ๐บ๐ธ USA |